Skip to main content

Raiffeisen Bank International AG

Bank

Position in IOVA — Iovance Biotherapeutics, Inc.

CIK 2044885 VIENNA, C4

Position in IOVA

as of Jun 30, 2026 · filed Aug 3, 2026
Position Value
$1,580,800
+$247,000 QoQ
Shares Held
380,000
0.0% QoQ
Ownership
0.084%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#66
of 292 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in IOVA Over Time

Shares Held

Position Value (USD)

Derivatives in IOVA

reported options exposure · as of Jun 30, 2026
CallValue
$8,320
CallShares
2,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Raiffeisen Bank International AG holds $103,697,949 across 27 Biotechnology names. IOVA ranks #9 (1.5% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in IOVA

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,580,800 380,000
2026-06-30 $8,320 2,000
2026-03-31 $1,333,800 380,000
2026-03-31 $7,020 2,000
2025-12-31 $1,228,500 450,000
2025-12-31 $5,460 2,000
2025-09-30 $520,800 240,000
2025-09-30 $4,340 2,000
2025-06-30 $252,840 147,000
2025-03-31 $489,510 147,000
2024-12-31 $754,800 102,000